pyrazolanthrone has been researched along with Melanoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Muthusamy, V; Piva, TJ | 1 |
| Fukushima, S; Hirano, A; Ihn, H; Inoue, Y; Ishihara, T; Jinnin, M; Kobayashi, Y; Kogushi-Nishi, H; Makino, T; Masuguchi, S; Muchemwa, FC | 1 |
| Garg, B; Garg, K; Pathria, G; Wagner, C; Wagner, SN | 1 |
| Alexaki, VI; Javelaud, D; Mauviel, A | 1 |
| Doudican, NA; Orlow, SJ; Quay, E; Zhang, S | 1 |
| Chakraborty, NG; Chattopadhyay, S; Chhabra, A; Dorsky, DI; Mehrotra, S; Mukherji, B | 1 |
| Chakraborty, NG; Chhabra, A; Dorsky, DI; Mehrotra, S; Mukherji, B | 1 |
7 other study(ies) available for pyrazolanthrone and Melanoma
| Article | Year |
|---|---|
UVB-stimulated TNFα release from human melanocyte and melanoma cells is mediated by p38 MAPK.
Topics: Anisomycin; Anthracenes; Cell Line, Tumor; Cell Survival; Humans; Imidazoles; Interleukin-1alpha; MAP Kinase Signaling System; Melanocytes; Melanoma; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Processing, Post-Translational; Pyridines; Sulfasalazine; Tumor Necrosis Factor-alpha | 2013 |
Role of c-Jun N-terminal kinase isoforms in the cellular activity of melanoma cell lines.
Topics: Anthracenes; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Immunoblotting; JNK Mitogen-Activated Protein Kinases; Melanoma; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Neoplasm Invasiveness; Protein Isoforms; Skin Neoplasms | 2013 |
Dual c-Jun N-terminal kinase-cyclin D1 and extracellular signal-related kinase-c-Jun disjunction in human melanoma.
Topics: Anthracenes; Cell Proliferation; Cyclin D1; Humans; JNK Mitogen-Activated Protein Kinases; Melanoma; Protein Kinase Inhibitors; Signal Transduction; Skin Neoplasms; Tumor Cells, Cultured | 2016 |
JNK supports survival in melanoma cells by controlling cell cycle arrest and apoptosis.
Topics: Animals; Anthracenes; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Humans; JNK Mitogen-Activated Protein Kinases; Melanoma; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; RNA, Small Interfering; Tumor Cells, Cultured | 2008 |
Fluvastatin enhances sorafenib cytotoxicity in melanoma cells via modulation of AKT and JNK signaling pathways.
Topics: Anthracenes; Benzenesulfonates; Cell Death; Cell Line, Tumor; Cell Proliferation; Chromones; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; Melanoma; Morpholines; Niacinamide; Phenylurea Compounds; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Pyridines; Signal Transduction; Sorafenib | 2011 |
Rescuing melanoma epitope-specific cytolytic T lymphocytes from activation-induced cell death, by SP600125, an inhibitor of JNK: implications in cancer immunotherapy.
Topics: Anthracenes; Antigen Presentation; Cell Death; Cell Line, Tumor; Cells, Cultured; Coculture Techniques; Cytotoxicity, Immunologic; Enzyme Inhibitors; Epitopes; Epitopes, T-Lymphocyte; Humans; Immunodominant Epitopes; Immunotherapy, Adoptive; Interferon-gamma; Interleukin-15; JNK Mitogen-Activated Protein Kinases; Lymphocyte Activation; Melanoma; Neoplasm Proteins; T-Lymphocytes, Cytotoxic | 2004 |
Activation-induced cell death of human melanoma specific cytotoxic T lymphocytes is mediated by apoptosis-inducing factor.
Topics: Anthracenes; Apoptosis; Apoptosis Inducing Factor; Humans; Jurkat Cells; Lymphocyte Activation; Melanoma; T-Lymphocytes, Cytotoxic; Tumor Cells, Cultured | 2006 |